Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

ClinicalTrials.gov ID: NCT01629966

Public ClinicalTrials.gov record NCT01629966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)

Study identification

NCT ID
NCT01629966
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
680 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 29, 2012
Primary completion
Feb 27, 2014
Completion
Mar 30, 2014
Last update posted
Dec 17, 2019

2012 – 2014

United States locations

U.S. sites
37
U.S. states
23
U.S. cities
34
Facility City State ZIP Site status
Forest Investigative Site 001 Birmingham Alabama 35216
Forest Investigative Site 021 Beverly Hills California 90210
Forest Investigative Site 023 Glendale California 91204
Forest Investigative Site 011 Paramount California 90723
Forest Investigative Site 026 Norwich Connecticut 06360
Forest Investigative Site 027 Waterbury Connecticut 06708
Forest Investigative Site 005 Delray Beach Florida 33484
Forest Investigative Site 014 Oakland Park Florida 33334
Forest Investigative Site 019 South Miami Florida 33143
Forest Investigative Site 038 Atlanta Georgia 30328
Forest Investigative Site 035 Decatur Georgia 30030
Forest Investigative Site 028 Chicago Illinois 60634
Forest Investigative Site 030 Schaumburg Illinois 60194
Forest Investigative Site 029 Topeka Kansas 66606
Forest Investigative Site 033 Wichita Kansas 67207
Forest Investigative Site 010 Lake Charles Louisiana 70629
Forest Investigative Site 031 Baltimore Maryland 21208
Forest Investigative Site 025 Boston Massachusetts 02114
Forest Investigative Site 037 St Louis Missouri 63104
Forest Investigative Site 015 Las Vegas Nevada 89103
Forest Investigative Site 016 Berlin New Jersey 08009
Forest Investigative Site 007 Brooklyn New York 11235
Forest Investigative Site 024 New York New York 10003
Forest Investigative Site 032 New York New York 10023
Forest Investigative Site 012 New York New York 10168
Forest Investigative Site 020 Bismarck North Dakota 58501
Forest Investigative Site 008 Cincinnati Ohio 45215
Forest Investigative Site 041 Dayton Ohio 45414
Forest Investigative Site 004 Oklahoma City Oklahoma 73112
Forest Investigative Site 034 Oklahoma City Oklahoma 73116
Forest Investigative Site 013 Portland Oregon 97210
Forest Investigative Site 006 Memphis Tennessee 38119
Forest Investigative Site 017 Wichita Falls Texas 76309
Forest Investigative Site 003 Salt Lake City Utah 84106
Forest Investigative Site 018 Charlottesville Virginia 22911
Forest Investigative Site 040 Bellevue Washington 98007
Forest Investigative Site 039 Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01629966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2019 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01629966 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →